Pangenomic Health Inc.
PGHIF
$1.46
$0.3632.74%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 32.40K | 32.30K | 32.70K | 106.50K | 102.70K |
| Gross Profit | -32.40K | -32.30K | -32.70K | -106.50K | -102.70K |
| SG&A Expenses | 610.60K | 520.80K | 1.12M | 190.00K | 171.10K |
| Depreciation & Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 643.10K | 553.20K | 1.16M | 296.60K | 273.90K |
| Operating Income | -643.10K | -553.20K | -1.16M | -296.60K | -273.90K |
| Income Before Tax | -665.70K | -624.90K | -1.28M | -286.90K | -279.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -665.70K | -624.90K | -1.28M | -286.90K | -279.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -665.70K | -624.90K | -1.28M | -286.90K | -279.10K |
| EBIT | -643.10K | -553.20K | -1.16M | -296.60K | -273.90K |
| EBITDA | -643.00K | -553.10K | -1.16M | -296.50K | -273.80K |
| EPS Basic | -0.03 | -0.02 | -0.08 | -0.02 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.05 | -0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.02 | -0.08 | -0.02 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.05 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 25.60M | 25.82M | 15.58M | 13.94M | 7.23M |
| Average Diluted Shares Outstanding | 25.60M | 25.82M | 15.58M | 13.94M | 7.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |